CompuGroup Medical SE & Co. KGaA

CompuGroup Medical SE & Co. KGaA

CMPVF
CompuGroup Medical SE & Co. KGaAUS flagOther OTC
33.66
USD
+3.51
- -
1.74BMarket Cap
2012 Y
2013 Y
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
TTM
Revenue per Share
9.06
9.24
10.36
10.92
11.27
11.71
14.57
15.41
15.58
19.59
21.63
22.74
- -
22.35
Basic EPS, GAAP
0.62
0.47
0.52
0.77
0.9
0.63
1.95
1.36
1.36
1.32
1.41
0.88
- -
0.52
Free Cash Flow per Basic Share
1.35
0.57
0.64
1.47
1.36
1.73
2.77
2.28
2.79
3.16
2.78
3.44
- -
2.78
Dividend per Share
0.25
0.35
0.35
0.35
0.35
0.35
0.35
0.5
0.45
0.5
0.5
0.5
- -
1
Book Value per Share
1.07
1.07
1.07
1.07
1.07
1.07
1.08
1.1
1
1.03
1.03
1.03
- -
1.04
Tangible Book Value per Share
-5.56
-6.1
-6.88
-7.07
-6.43
-6.26
-5.54
-8.44
-8.36
-11.5
-11.87
-12.26
- -
-13.35
Basic Weighted Avg Shares
50
50
50
50
50
50
49
48
54
52
52
52
- -
52
Sales/Revenue/Turnover
451
460
515
543
560
582
717
746
837
1,025
1,130
1,188
1,154
1,156
Operating Margin (%)
14.55
11.98
8.37
12.23
14.05
15.81
20.2
15.95
14.97
10.52
9.51
10.35
9.16
8.68
Depreciation Expense
41
41
43
45
44
38
45
63
76
111
112
116
112
112
Net Income, GAAP
31
23
26
38
45
31
96
66
73
69
73
46
35
27
Effective Tax Rate (%)
37.11
37.02
45.92
37.91
40.08
51.58
28.16
38.6
33.51
29.47
30.61
35.5
43.84
46.66
Profit Margin (%)
6.82
5.04
5.05
7.09
7.95
5.37
13.4
8.83
8.74
6.73
6.5
3.87
3
2.34
Working Capital
-66
-31
2
-29
-10
-16
9
-3
18
-28
45
23
63
50
LT Debt
225
278
344
326
328
318
320
453
498
626
733
741
826
795
Total Equity
179
183
176
193
219
223
264
260
639
612
674
669
648
652
Return on Invested Capital (%)
8.72
6.94
4.32
7.04
7.64
7.47
17.59
10.45
8.34
5.89
5.21
5.29
3.85
3.56
Return on Capital (%)
12.25
9.47
9.23
10.68
11.67
8.24
25.32
14.51
13.16
10.36
9.66
7.29
6.06
5.21
Return on Common Equity (%)
57.72
43.49
48.86
72.33
83.67
58.72
180.55
123.68
136.87
128.35
136.62
85.45
64.39
50.24

Capital Structure

FRC

in mil. unless spec.
Sep'24
Dec'24
Mar'25
ST Debt
75
54
31
LT Borrowings
743
794
765
LT Finance Leases
33
32
31
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
52
52
52
Market Capitalization
839
904
1,140

Working Capital

FRC

in mil. unless spec.
Sep'24
Dec'24
Mar'25
Total Current Assets
378
395
462
Cash, Cash Equivalents & STI
80
108
129
Accounts Receivable, Net
170
167
208
Inventories
19
15
15
Total Current Liabilities
366
331
412
Payables & Accruals
- -
- -
- -
ST Debt
75
54
31
Deferred Revenue
- -
- -
- -

Growth Rates

FRC

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
18.99%
29.58%
-3.13%
Free Cash Flow
21.77%
5.85%
-28.21%
Net Income, GAAP
15.96%
-10.05%
-24.65%
Sales/Revenue/Turnover
8.69%
9.44%
-2.84%
Total Cash Common Dividend
- -
- -
98.09%

Quarterly Revenue

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2023
291
304
286
307
1,188
2024
285
277
283
309
1,154
2025
286
- -
- -
- -
- -

Quarterly Earnings Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2023
0.28
0.6
0.31
- -
0.88
2024
0.35
0.27
0.17
- -
- -
2025
- -
- -
- -
- -
- -

Quarterly Dividends Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2023
- -
0.5
- -
- -
0.5
2024
- -
1
- -
- -
- -
2025
- -
- -
- -
- -
- -

Company Description

APIChat
CEO
Daniel Gotthardt
Full Time Employees
8,299
Sector
Healthcare
Industry
Medical - Healthcare Information Services
Address
Maria Trost 21 Koblenz Germany 56070
IPO Date
Apr 10, 2013
Website
cgm.com
Business
CompuGroup Medical SE & Co. KGaA develops and provides e-health software solutions supporting medical and organizational activities in physicians' practices, pharmacies, laboratories, hospitals, and care facilities worldwide; its core offerings span Ambulatory Information Systems (AIS) including practice management software for registered physicians, medical care centers, and physician networks covering clinical, administrative, and billing functions; Pharmacy Information Systems (PCS) with integrated administrative, billing, and supply chain applications for medication procurement, inventory management, and retail operations; Hospital Information Systems (HIS) delivering clinical and administrative solutions for inpatient care such as admission, medication, surgery, and discharge processes; additional products encompass laboratory information systems, electronic health records, drug information systems, web-based patient files, medical archiving, referring physician portals, revenue cycle management services, EDI clearinghouse capabilities, AI-powered tools for faxes and scans, and cloud-based connectivity solutions. The company, founded in 1987 by Frank Gotthardt and headquartered in Koblenz, Germany, operates in over 60 countries across Europe, North America, Asia, Africa, and beyond with more than 8,700 employees serving over 1.6 million users including doctors, dentists, pharmacists, insurers, and inpatient/outpatient facilities. In recent developments, CompuGroup Medical entered a strategic partnership with CVC Capital Partners in December 2024, culminating in CVC's acquisition of a approximately 28% stake, the company's delisting from public exchanges in June 2025 while the founding family retains majority control, and the acquisition of Norwegian firm Pridok in 2024 to bolster its Northern European market position in interoperability solutions; further enhancements include expanded AI and cloud-based products, leadership transition with Prof. Dr. Daniel Gotthardt as CEO since September 2024, and significant adoption in electronic prescriptions handling 30% of Germany's GP e-prescriptions post-2024 nationwide rollout.